News

The neurotechnology market opportunity for treating Alzheimer’s disease has shown steady progress in recent months as several commercial firms and research organizations have reported advances. Some well publicized setbacks from pharmaceutical firms in this space have also contributed to a new sense of optimism for device interventions. Many investigators and entrepreneurs in this space have chosen…

Neurotech Reports, the publisher of this newsletter, announced the winners of the 2023 Gold Electrode Awards during the 2023 Neurotech Leaders Forum, which took place in November in San Francisco. The award for best new product went to Neuromod Devices for its Lenire system for treating tinnitus. The award for most promising startup went to Salvia BioElectronics, which is developing a new minimally invasive neuromodulation system for migraine.

The bioelectronic medicine market for treating bowel and bladder disorders underwent a significant transformation earlier this month with the news of the largest M&A deal in the industry’s history. On January 8, Axonics, Inc. announced that it has entered into a definitive agreement to be acquired . for $71 in cash per share, representing an equity value of approximately $3.7 billion. Axonics brings a complementary product portfolio to the Boston Scientific urology business.

The dissemination of bioelectronic medicine therapies is based, to a large extent, on ambulatory surgery centers that perform a majority of minimally invasive surgeries, including medical device implantation and replacement. Implantation procedures performed at ASCs are typically less expensive than those performed at hospitals. As one example, surgery for implanting SNS devices made (CPT codes 645…

The field of noninvasive neuromodulation has witnessed significant growth in recent years, with hundreds of companies targeting various disorders such as pain, vestibular disorders, tinnitus, Alzheimer’s, and various wellness conditions. While the majority of these companies utilize electrical stimulation, other modalities, including magnetic, ultrasound, and optical, have also been explored. More…

The North American Neuromodulation Society opened 2024 with a celebration of its 30th anniversary. The conference has grown over its lifetime from a few hundred attendees in its infancy to more than 3000 in attendance this year. A significant factor in the society’s growth has been the inclusion of novel program elements including several pre-conference workshops ranging from cadaver labs to commercially oriented programs such as i3—Invention, Investment, and Invigoration.

When we closed out the year 2023 in this space last month on a somewhat optimistic note, we really had no idea how quickly good fortune would visit the neurotechnology industry. But in fact, January 2024 proved to be a landmark month for startups, strategics, and investors in the space. Just in case Neuralink founder Elon Musk doesn’t get enough news coverage, his announcement of the first-in-human implantation of the company’s robotic-driven BCI system was greeted even a significant milestone.

About 110 neurotechnology industry professionals, including founders of startup-firms, executives of larger companies, clinicians, university researchers, investors, and government representatives, took part in a series of discussions at the 2023 Neurotech Leaders Forum, produced . Several of the sessions featured lively though respectful debates on critical issues facing the industry, including fu…

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event—the most established in the industry—will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

As we bid farewell to another year, it’s worth taking a look at some of the more significant events that took place in the neurotechnology industry in 2023. While the industry has not yet returned to the levels of investment and valuations of 2021, there is certainly more optimism among startups in this space compared to a year ago. Among the neurotech startups and emerging firms who fared well thi…